Shingles vaccine linked to 9% lower cardiovascular burden in new study
Share on Pinterest Shingrix, the current vaccine against shingles, is linked to a lower burden of cardiovascular problems. FG Trade…
Category: News
Breaking health news, medical updates, policy changes, and public health developments from around the world. We deliver timely, accurate health journalism to keep you informed and aware.
Breast cancer survivors could avoid lifelong heart medication, research suggests
Many breast cancer survivors whose treatment caused them to develop problems with their heart function can safely stop their medication after their heart recovers and most won’t need to continue treatment long-term, according to a study…
Remote exercise-based cardiac rehabilitation can be an additional option for heart patients
Remotely delivered exercise-based cardiac rehabilitation, when added to center-based programs, resulted in a similar number of completed sessions as center-based…
Rapid pathway for diagnosing heart attacks does not improve emergency discharge rates
A rapid pathway for diagnosing heart attacks in the emergency department (ED) was as safe as a slower pathway but…
Functional angiography outperforms conventional imaging in AIR-STEMI trial
Functional coronary angiography significantly reduced cardiovascular events and improved safety compared with conventional angiography in patients with ST-segment elevation myocardial…
Digital registry strategy doubles heart failure treatment uptake
A registry-based digital strategy that identified untreated patients and invited them to a telephone consultation more than doubled implementation of an effective type of heart failure treatment. These results…
FDA approves daraxonrasib for patients with metastatic pancreatic cancer
The U.S. Food and Drug Administration (FDA) has approved daraxonrasib for patients whose pancreatic cancer has spread to other parts…
SWITCH SWEDEHEART trial shows prasugrel matches ticagrelor with less bleeding
Prasugrel reduced major cardiovascular events to the same extent as ticagrelor but with lower major bleeding after coronary stenting in…
Trial shows antiplatelet therapy needs personalization after stent implantation
Antiplatelet monotherapy reduced bleeding but dual therapy provided greater cardiovascular event protection in patients at high ischemic risk who had…
Milvexian fails to reduce cardiovascular events after acute coronary syndrome
Milvexian did not reduce major adverse cardiovascular events compared with placebo after a recent acute coronary syndrome and there was…